A Drug–Drug Multicomponent Crystal of Metformin and Dobesilate: Crystal Structure Analysis and Hygroscopicity Property
A drug–drug multicomponent crystal consisting of metformin (MET) and dobesilate (DBS) was prospectively connected by solvent cooling and evaporating co-crystallization using the multicomponent crystal strategy, not only to optimize the physicochemical properties of single drugs, but also to play a r...
Main Authors: | Lan Jiang, Xiangnan Hu, Linhong Cai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/11/3472 |
Similar Items
-
Multicomponent Crystal of Metformin and Barbital: Design, Crystal Structure Analysis and Characterization
by: Linhong Cai, et al.
Published: (2021-07-01) -
A Glimepiride-Metformin Multidrug Crystal: Synthesis, Crystal Structure Analysis, and Physicochemical Properties
by: Xufei Bian, et al.
Published: (2019-10-01) -
Effect of calcium dobesilate on vitreous hemorrhage in patients with PDR after pan retinal photocoagulation
by: Yan-Xia Lu, et al.
Published: (2018-07-01) -
Effect of calcium dobesilate combined with panretinal photocoagulation on severe non-proliferative diabetic retinopathy patients
by: Gao-Chun Li, et al.
Published: (2018-04-01) -
Clinical effect of PRP combined with calcium dobesilate in treatment of patients with DR
by: Li-Bo Wang, et al.
Published: (2017-09-01)